These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 269322)

  • 1. Presence of complement-fixing antibodies against antigens of Gross virus-induced rat lymphoma and normal rat thymus in sera of patients with some forms of malignancies.
    Simkovic D; Chorváth B; Hlubinová K; Valentová N; Stevonková J; Babusíková O; Simkovicová M
    Neoplasma; 1977; 24(4):357-63. PubMed ID: 269322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-fixing soluble antigen from rat lymphoma (C58NT)D. Preliminary characterization of the antigen and some positive human sera.
    Chorváth B; Hlubinová K; Simkovic D
    Neoplasma; 1978; 25(3):279-83. PubMed ID: 79985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies presumably cross-reacting with mouse retrovirus type B and C in the sera of both leukemia-lymphoma and mammary cancer patients.
    Segal-Eiras A; Croce MV; Pasqualini CD
    Arch Geschwulstforsch; 1983; 53(4):321-7. PubMed ID: 6312922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti--DNA antibodies in patients with leukemia and lymphoma.
    Izui S; Lambert PH; Carpentier NA; Miescher PA
    Schweiz Med Wochenschr; 1976 Oct; 106(40):1377-8. PubMed ID: 1087460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
    Ishimoto A; Ito Y
    Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
    Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
    Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificities of heterologous antisera against human leukaemia cells. 1. Reactions against leukaemia cells.
    Thränhardt H; Milleck J; Zintl F; Koppitz D; Plenert W; Raderecht C; Richter KV
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(4):463-74. PubMed ID: 83265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paul-Bunnell antigen in lymphoma and leukemia spleens.
    Kano K; Fjelde A; Milgrom F
    J Immunol; 1977 Sep; 119(3):945-9. PubMed ID: 268381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of soluble tumor-associated antigens in serum of tumor-bearing rats and their immunological role in vivo.
    Srinivasa Rao V; Bonavida B
    Cancer Res; 1977 Sep; 37(9):3385-9. PubMed ID: 884683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on Paul-Bunnell (P-B) antigen-antibody system. II. P-B antigens in extracts of lymphoma-leukemia spleens and pathologic sera.
    Masaki M; Kano K; Merrick JM; Milgrom F
    J Immunol; 1981 Jul; 127(1):5-8. PubMed ID: 6972412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of antibodies to soluble blast cell antigens in acute leukemia].
    Golodnenkova VN; Bulycheva TI; Danilevich SV
    Vopr Onkol; 1980; 26(9):17-22. PubMed ID: 6932783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytotoxic antibodies to leukemia cells in normal human sera].
    Dorè JF; Bertoglio J; Guibout C
    Ann Immunol (Paris); 1977; 128(1-2):155-7. PubMed ID: 265695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies cross-reacting with Gross virus detected in human acute leukemia and Hodgkin lymphoma.
    Dosne Pasqualini C; Di Girolamo MT; Segal Eiras A; Laguens RP
    Medicina (B Aires); 1980; 40(3):289-94. PubMed ID: 7001168
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunity in leukemia.
    Gatti RA
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:275-81. PubMed ID: 4277522
    [No Abstract]   [Full Text] [Related]  

  • 15. Autogenous immunity to endogenous RNA tumor virus antigens in mice with a low natural incidence of lymphoma.
    Hanna MG; Tennant RW; Yuhas JM; Clapp NK; Batzing BL; Snodgrass MJ
    Cancer Res; 1972 Oct; 32(10):2226-34. PubMed ID: 4117035
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunofluorescence studies in human leukemia.
    Bates HA; Bankole RO; Swaim WR
    Blood; 1969 Oct; 34(4):431-40. PubMed ID: 4309683
    [No Abstract]   [Full Text] [Related]  

  • 17. Augmentation of cell-mediated cytotoxicity against syngeneic Gross virus-induced lymphoma in rats by phytohemagglutinin and endotoxin.
    Glaser M; Djeu JY; Kirchner H; Herberman RB
    J Immunol; 1976 Jun; 116(6):1512-9. PubMed ID: 774985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-ATLA (antibody to adult T-cell leukemia virus-associated antigen), highly positive in OKT4-positive mature T-cell malignancies.
    Tobinai K; Nagai M; Setoya T; Shibata T; Minato K; Shimoyama M
    Jpn J Clin Oncol; 1983; 13 Suppl 2():237-44. PubMed ID: 6603532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibodies against the Epstein-Barr Virus nuclear-antigen in children with malignant disease (author's transl)].
    Lubec G; Jürgenssen O
    Osterr Z Onkol; 1976; 3(4):96-9. PubMed ID: 189271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement fixing antibody to varicella-zoster virus in cancerous patients.
    Peserico A; Moschen ME; Romano M; Cartei G; Crivellari D; Trivello R
    Boll Ist Sieroter Milan; 1979 Sep; 58(4):335-8. PubMed ID: 233341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.